Recro Pharma (REPH) Enters Revised Milestone Payment Agreement with Alkermes (ALKS)
Tweet Send to a Friend
Recro Pharma (NASDAQ: REPH) disclosed the following in a U.S. SEC filing on Thursday:Item 1.01 Entry into a Material Definitive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
